• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯噻嗪和氨苯蝶啶单独或联合使用对大鼠电解质排泄的影响。

Effects of xipamide and triamterene - alone or in combination - on electrolyte excretion in the rat.

作者信息

Hohenegger M, Holzer F

出版信息

Int J Clin Pharmacol Biopharm. 1976 Jun;13(4):298-303.

PMID:965134
Abstract

The effects of X and T in different doses alone or in combination on renal sodium and potassium excretion were examined in conscious rats. In acute experiments, the combination of both diuretics produced an approximately additive effect on sodium excretion. Addition of T to X in different dose relations (X:T = 1:0.5, 1:1 or 1:1.5) prevented the X-induced potassium loss. These effects were more pronounced at the highest dose of T; the difference to the other combinations, however, was small. In chronic experiments, when the diuretics were administered daily for 13 days, both combinations (X:T = 1:1 and X:T = 1:1.5) resulted in a nearly equilibrated potassium balance at the end of this period. In shorter intervals, however, sometimes considerable oscillations in potassium excretion occured.

摘要

在清醒大鼠中研究了不同剂量的X和T单独或联合使用对肾钠和钾排泄的影响。在急性实验中,两种利尿剂联合使用对钠排泄产生了近似相加的作用。以不同剂量比例(X:T = 1:0.5、1:1或1:1.5)将T添加到X中可防止X诱导的钾流失。这些作用在T的最高剂量时更为明显;然而,与其他组合的差异很小。在慢性实验中,当利尿剂每日给药13天时,两种组合(X:T = 1:1和X:T = 1:1.5)在此期间结束时导致钾平衡几乎达到平衡。然而,在较短的时间间隔内,钾排泄有时会出现相当大的波动。

相似文献

1
Effects of xipamide and triamterene - alone or in combination - on electrolyte excretion in the rat.氯噻嗪和氨苯蝶啶单独或联合使用对大鼠电解质排泄的影响。
Int J Clin Pharmacol Biopharm. 1976 Jun;13(4):298-303.
2
[Saluretic and diuretic effects of xipamide-triamterene combinations in varying dose ratios in rats].[不同剂量比例的氯磺水杨胺-氨苯蝶啶组合对大鼠的利钠和利尿作用]
Arzneimittelforschung. 1983;33(1):131-5.
3
Acute and chronic diuretic-induced alterations in urinary sodium and calcium excretion in the conscious rat.清醒大鼠中急性和慢性利尿剂诱导的尿钠和钙排泄变化
Miner Electrolyte Metab. 1982 Dec;8(6):314-24.
4
Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.氨苯蝶啶和氢氯噻嗪及其组合在健康志愿者体内的药代动力学和药效学
Int J Clin Pharmacol Ther. 1997 Oct;35(10):447-52.
5
[Diuretic and saluretic effects of bemetizide and triamterene compared to those of their combination (author's transl)].苄氟噻嗪和氨苯蝶啶及其联合用药的利尿和促尿钠排泄作用比较(作者译)
Arzneimittelforschung. 1977;27(3):559-62.
6
[Pharmacological and toxicological properties of the saluretic xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide)].[利尿素氯磺水杨胺(4-氯-5-氨磺酰基-2',6'-水杨酰替苯胺)的药理和毒理学特性]
Arzneimittelforschung. 1975 Feb;25(2):245-51.
7
[Effect of the diuretics bemetizide and triamterene on renal excretion of potassium and sodium. Animal experiments].
Med Welt. 1977 Oct 7;28(40):1621-3.
8
[Diuresis and natriuresis following application of bemeticide and triamterence in rats on normal and low-potassium diet (author's transl)].正常饮食和低钾饮食大鼠应用灭草隆和氨苯蝶啶后的利尿和利钠作用(作者译)
Arzneimittelforschung. 1977;27(5):1026-34.
9
[Comparative study of potassium-sparing effects of triamterene and amiloride in the treatment with hydrochlorothiazide].氨苯蝶啶和阿米洛利在与氢氯噻嗪联合治疗中保钾作用的比较研究
Klin Med (Mosk). 1990 Sep;68(9):61-4.
10
[Diuretics. 5. Effects of single or combined administration of diuretics in normal or spontaneously hypertensive rats].
Nihon Yakurigaku Zasshi. 1972 May;68(3):276-89.

引用本文的文献

1
Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.氯噻嗪。对其药效学、药代动力学特性及治疗效果的综述。
Drugs. 1985 Oct;30(4):313-32. doi: 10.2165/00003495-198530040-00002.
2
Pharmacodynamics and pharmacokinetics of furosemide combinations with potassium-retaining and thiazide-like diuretics: clearance and micropuncture studies.速尿与保钾利尿剂及噻嗪样利尿剂联合应用的药效学和药代动力学:清除率及微穿刺研究
Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug;333(4):457-61. doi: 10.1007/BF00500025.